[ Diabetes Solutions ]

Genetic Engineering and Mutations

The American Juvenile Diabetes Association estimates that about 3 million Americans suffer from type 1 diabetes. Genetic engineering can cure most illnesses and diseases. Today genetically engineered microbes are used to “manufacture” insulin that’s far safer, more humane and cost-efficient. The other main medical treatment that now commonly contains GMOs is vaccines. naked DNA injections, micro-seeding, liposomal reagents, particle bombardment, and electroporation). Animal Insulin Revision about Chromosome, DNA, gene A gene is a section of DNA that carries the code for a particular protein. Diabetes, a medical condition that affects millions of people, prevents the body from producing enough insulin necessary for cells to properly absorb sugar.

] from one organism, and join them into a gap in the DNA of another organism. Notice that enzymes [enzyme: Proteins which catalyse or speed up chemical reactions inside our bodies. Glucokinase (GK) is the enzyme that senses glucose in the pancreas. And it doesnt stop there: many of the genetically modified crops now being field-tested in the United States and around the world could not only have a devastating Jurassic Park type impact on the global eco-system, but could also hit agriculture-based third-world economies dependent on cash crops. Pharmaceutical companies now use genetic engineering to produce large quantities of insulin for diabetics around the world. There are four different nitrogen bases, adenine, thymine

Tags: , ,
[ Nutrition ]

Lidocaine for Diabetic Peripheral Neuropathy – Full Text View


It has also been recommended that people with peripheral diabetic neuropathy that have reduced or absent feeling in their feet should not engage in any form of weight bearing exercise activity. Symptoms include numbness, tingling or prickling in the toes or fingers in early stages. We compared the prevalence of other diabetes-related complications or comorbidities between patients with Type 1 and with Type 2 diabetes. Pregabalin and duloxetine are the only medications approved by the U.S. Researchers studied data on 467 individuals in the longitudinal Prospective Metabolism and Islet Cell Evaluation (PROMISE) cohort. The age of patients, their sex, and the duration of underlying diabetes were found to be statistically significant factors in the development of painful diabetic peripheral neuropathy. Mean corrected spinal cord area index (SCAI) (corrected for age, height, and weight) was 67.5 mm [95% CI 64.1-70.9] in diabetic subjects without DPN.

This study suggests that peripheral neuropathy is not a problem in just older diabetic patients, but is prevalent in the younger diabetic population as well. At the completion of the study (day 40 post-STZ), histological examination revealed significant axonopathy and myelin loss, along with an increase in the proportion of fibers with abnormal appearance in sciatic nerves of STZ rats. Reeves, who is running a three-year project to investigate biomechanical and neuromuscular factors that may compromise the safety of patients

Tags: , ,